Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants (NOCI-Prem)

January 27, 2023 updated by: University Hospital, Strasbourg, France
The management of pain related to venipuncture remains insufficient in very preterm infants (VPI. The separation between the mother (father) and her(his) child can aggravate the short-term painful experience of the newborn. Accurate diagnosis and treatment of pain is necessary to preserve the well-being and brain development of VPI. A better understanding of the development of pain pathways and the cortical integration of nociceptive messages is essential to reach this goal.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Strasbourg, France, 67000
        • Recruiting
        • Service de Pédiatrie - Hôpital d'Hautepierre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Experimental group: VPIs of gestational age less than or equal to 33 weeks on the day of birth and hospitalized in the neonatal intermediate care unit or the neonatal intensive care unit of the Neonatal department of the Hautepierre Hospital (Strasbourg University Hospital)

    • Control group: Healthy full-term babies (> 37 weeks gestational age) hospitalized in the maternity ward of Strasbourg University Hospital
    • Consent obtained from both parents
    • Subject affiliated to a social health insurance plan.

Exclusion Criteria:

  • - Any malformation known before inclusion
  • Cerebral lesions discovered on cerebral ultrasound performed as part of the standard management of newborns (Intra-Ventricular Hemorrhages of grade III or IV of the Papile classification, Periventricular Leucomalacia)
  • Unstable clinical status according to the investigator's judgment
  • Expected transfer of the child to another hospital before the term of 40 weeks PMAs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Very preterm infant
Preterm infant below 33 weeks of GA

Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant.

In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

Active Comparator: Full term neonate
Term neonate from a gestational age of 37 weeks.

Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant.

In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The cortical hemodynamic response profile
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
The cortical hemodynamic response profile
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
The cortical hemodynamic response profile
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
The cortical hemodynamic response profile
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes. The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification. The data set will be collected over a basal period, a stimulation period and a post-stimulation period. Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates. A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
During a venipuncture at 2 to 3 days of life in term neonates

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
During a venipuncture at 2 to 3 days of life in term neonates
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
During a venipuncture at 2 to 3 days of life in term neonates
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Comparison of the response profiles obtained in females and males
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Comparison of the response profiles obtained in females and males
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Comparison of the response profiles obtained in females and males
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Comparison of the response profiles obtained in females and males
During a venipuncture at 2 to 3 days of life in term neonates
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
During a venipuncture at 2 to 3 days of life in term neonates
Correlational analyses by APM group
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Correlational analyses by APM group
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Correlational analyses by APM group
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Correlational analyses by APM group
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
During a venipuncture at 2 to 3 days of life in term neonates
Facial pain behavior
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Facial pain behavior with the Neonatal Facial Coding System
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Facial pain behavior
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Facial pain behavior with the Neonatal Facial Coding System
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Facial pain behavior
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Facial pain behavior with the Neonatal Facial Coding System
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Facial pain behavior
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Facial pain behavior with the Neonatal Facial Coding System
During a venipuncture at 2 to 3 days of life in term neonates
Pain index
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Pain index assessing the sympathetic and parasympathetic system
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Pain index
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Pain index assessing the sympathetic and parasympathetic system
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Pain index
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Pain index assessing the sympathetic and parasympathetic system
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Pain index
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Pain index assessing the sympathetic and parasympathetic system
During a venipuncture at 2 to 3 days of life in term neonates
Cortical evoked potentials
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Cortical evoked potentials in Cz according to EEG 10:20 classification
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
Cortical evoked potentials
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Cortical evoked potentials in Cz according to EEG 10:20 classification
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
Cortical evoked potentials
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Cortical evoked potentials in Cz according to EEG 10:20 classification
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
Cortical evoked potentials
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
Cortical evoked potentials in Cz according to EEG 10:20 classification
During a venipuncture at 2 to 3 days of life in term neonates

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 17, 2019

Primary Completion (Anticipated)

April 17, 2023

Study Completion (Anticipated)

April 17, 2023

Study Registration Dates

First Submitted

February 21, 2022

First Submitted That Met QC Criteria

May 31, 2022

First Posted (Actual)

June 3, 2022

Study Record Updates

Last Update Posted (Estimate)

January 30, 2023

Last Update Submitted That Met QC Criteria

January 27, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Procedural Pain

Clinical Trials on Maternal vocal contact

Subscribe